Although we observed a highly significant difference in proportions of Foxp3− and Foxp3+ T cells expressing CCR4 in spleens and lymph nodes, this difference was considerably reduced in the tumour where CCR4 was expressed on a high proportion of both Foxp3− and Foxp3+ T cells (Fig.3). This evidence concerns the gene CCR4 and neoplasm.